Declaration of storage conditions for medicinal products particulars and active substances (Annex) - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document aims to set out uniform statements on storage conditions for inclusion in the labelling of medicinal products and to define when they apply. It is intended as an annex to stability guidelines and relates to marketing authorisations for all product categories.
Keywords: Stability, storage conditions, storage statement, product information, packagel leaflet, labelling
Current effective version
Related content
- Quality: stability
ICH: E 12: Principles for clinical evaluation of new antihypertensive drugs - Step 5- Guideline on summary of product characteristics (SmPC)
- ICH Q1A (R2) Stability testing of new drug substances and drug products
- ICH Q1B Photostability testing of new active substances and medicinal products
- ICH Q1E Evaluation of stability data
- In-use stability testing of human medicinal products
- Maximum shelf-life for sterile products for human use after first opening or following reconstitution
- Stability testing of existing active ingredients and related finished products